Related Experiment Video

Updated: May 16, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

MEK1 and MEK2 differentially regulate human insulin- and insulin glargine-induced human bladder cancer T24 cell

Shan-Ying Liu1, Ying Liang, Tian-Xin Lin

  • 1Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510120, China.

Chinese Medical Journal
|December 11, 2012
PubMed
Abstract

Insights

Mitogen-activated protein kinase kinase (MEK) 1 inhibits bladder cancer cell growth, while MEK2 promotes it. Both insulin and insulin glargine-induced proliferation rely on MEK2, highlighting their distinct roles in bladder cancer progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Diabetic patients exhibit an elevated risk of bladder cancer.
  • Investigating the role of MEK1 and MEK2 in bladder cancer cell proliferation is crucial.

Purpose of the Study:

  • To elucidate the specific roles of mitogen-activated protein kinase kinase (MEK) 1 and MEK2.
  • To understand their regulation of human insulin and insulin glargine-induced proliferation in T24 bladder cancer cells.

Main Methods:

  • T24 cell proliferation was assessed using CCK-8 assays with MEK1 inhibitor (PD98059) or MEK2 siRNA (siMEK2).
  • Protein expression and phosphorylation of key signaling molecules (MEK2, ERK1/2, Akt) were analyzed via Western blotting.

Main Results:

  • MEK1 inhibition (PD98059) promoted T24 cell proliferation, whereas MEK2 inhibition (siMEK2) suppressed it.
  • Both insulin and insulin glargine enhanced T24 cell proliferation, an effect blocked by MEK1/2 inhibition on ERK1/2 activation.
  • Insulin-induced proliferation was enhanced by MEK1 inhibition and suppressed by MEK2 inhibition, with MEK1/2 blocking ERK1/2 activation.

Conclusions:

  • MEK1 acts as an inhibitor of normal and insulin-stimulated T24 bladder cancer cell proliferation.
  • MEK2 contributes to both normal and insulin-stimulated T24 bladder cancer cell proliferation.
  • Differential roles of MEK1 and MEK2 in bladder cancer progression warrant further investigation.

More Related Videos

Mouse Bladder Wall Injection03:48

Mouse Bladder Wall Injection

Published on: July 12, 2011

An Orthotopic Bladder Cancer Model for Gene Delivery Studies07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...